Subsets of donor-origin B cells in BM
In vitro treatment . | B-lineage cells, % ± SD . | . | |
|---|---|---|---|
| . | Pre-pro-B and pro-B . | Pre-B and immature B . | |
| rIL-7 | 85.3 ± 11.8 | 14.4 ± 11.3 | |
| ScIL-7/HGFβ | 62.5 ± 16.7* | 36.8 ± 17.8* | |
| Normal BM cells | 61.4 ± 5.2 | 38.5 ± 5.2 | |
In vitro treatment . | B-lineage cells, % ± SD . | . | |
|---|---|---|---|
| . | Pre-pro-B and pro-B . | Pre-B and immature B . | |
| rIL-7 | 85.3 ± 11.8 | 14.4 ± 11.3 | |
| ScIL-7/HGFβ | 62.5 ± 16.7* | 36.8 ± 17.8* | |
| Normal BM cells | 61.4 ± 5.2 | 38.5 ± 5.2 | |
P < .05 between scIL-7/HGFβ– and rIL-7–treated cells